{"id":"NCT03039686","sponsor":"Hoffmann-La Roche","briefTitle":"Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy","officialTitle":"A Randomized, Double Blind, Placebo-Controlled, Study to Assess the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2017-07-06","primaryCompletion":"2020-04-28","completion":"2020-04-28","firstPosted":"2017-02-01","resultsPosted":"2020-12-21","lastUpdate":"2020-12-21"},"enrollment":166,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Duchenne Muscular Dystrophy"],"interventions":[{"type":"DRUG","name":"RO7239361","otherNames":[]},{"type":"DRUG","name":"Placebo for RO7239361","otherNames":[]}],"arms":[{"label":"RO7239361 Low Dose","type":"EXPERIMENTAL"},{"label":"RO7239361 High Dose","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of two different weekly doses of RO7239361 in ambulatory boys with Duchenne Muscular Dystrophy (DMD).","primaryOutcome":{"measure":"Baseline for the North Star Ambulatory Assessment (NSAA) Total Score","timeFrame":"Baseline","effectByArm":[{"arm":"Placebo","deltaMin":23.1,"sd":6.4},{"arm":"RO7239361 Low Dose","deltaMin":24.5,"sd":5.5},{"arm":"RO7239361 High Dose","deltaMin":22.7,"sd":6.7}],"pValues":[]},"eligibility":{"minAge":"6 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":5},"locations":{"siteCount":44,"countries":["United States","Argentina","Australia","Belgium","Canada","France","Germany","Italy","Japan","Netherlands","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["38190001"],"seeAlso":["http://www.fda.gov/Safety/Recalls/","http://roche-duchenne-clinicaltrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":56},"commonTop":["Nasopharyngitis","Headache","Injection site erythema","Pyrexia","Cough"]}}